An intermediate (2) useful in making capecitabine can be formed without the use, or presence, of a silylation agent.
Web www.patentalert.com
< Sugar and lipid metabolism regulators in plants II
> siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT